These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3267444)

  • 1. Impairment of human polymorphonuclear leukocyte chemotaxis by 2,5-hexanedione.
    Governa M; Valentino M; Visona I; Rocco M
    Cell Biol Toxicol; 1986 Mar; 2(1):33-9. PubMed ID: 3267444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of erythrocyte membrane fluidity in rats exposed to 2,5-hexanedione.
    Valentino M; Governa M; Rocco M; Zolese G; Bertoli E; Fiorini RM
    Boll Soc Ital Biol Sper; 1987 Jul; 63(7):629-33. PubMed ID: 3663365
    [No Abstract]   [Full Text] [Related]  

  • 3. Human polymorphonuclear leukocyte chemotaxis as a tool in detecting biological early effects in workers occupationally exposed to low levels of n-hexane.
    Governa M; Valentino M; Visonà I; Monaco F
    Hum Exp Toxicol; 1994 Oct; 13(10):663-70. PubMed ID: 7826683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Miconazole and amphotericin B alter polymorphonuclear leukocyte functions and membrane fluidity in similar fashions.
    Yasui K; Masuda M; Matsuoka T; Yamazaki M; Komiyama A; Akabane T; Murata K
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1864-8. PubMed ID: 3245698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of n-hexane, 2-hexanone, 2,5-hexanedione, and related chemicals by capillary gas chromatography and high-performance liquid chromatography.
    Nomeir AA; Abou-Donia MB
    Anal Biochem; 1985 Dec; 151(2):381-8. PubMed ID: 4096376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of 2,5-hexanedione and peripheral polyneuropathies workers exposed to hexane.
    Governa M; Calisti R; Coppa G; Tagliavento G; Colombi A; Troni W
    J Toxicol Environ Health; 1987; 20(3):219-28. PubMed ID: 3029393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotactic activity of human polymorphonuclear leukocytes and industrial xenobiotics: a brief review.
    Governa M; Valentino M; Visonà I
    Toxicology; 1994 Jul; 91(2):165-77. PubMed ID: 8059440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of n-hexane metabolites. A comparative study in rat, rabbit and monkey.
    Perbellini L; Amantini MC; Brugnone F; Frontali N
    Arch Toxicol; 1982 Sep; 50(3-4):203-15. PubMed ID: 7149986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of membrane fluidity in chemotactic peptide-stimulated polymorphonuclear leukocytes.
    Valentino M; Governa M; Fiorini R; Curatola G
    Biochem Biophys Res Commun; 1986 Dec; 141(3):1151-6. PubMed ID: 3814118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoskeletal changes induced in vitro by 2,5-hexanedione: an immunocytochemical study.
    Malorni W; Iosi F; Formisano G; Arancia G
    Exp Mol Pathol; 1989 Feb; 50(1):50-68. PubMed ID: 2920820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoattractant receptor functions in human polymorphonuclear leukocytes are divergently altered by membrane fluidizers.
    Yuli I; Tomonaga A; Synderman R
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):5906-10. PubMed ID: 6310554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorpromazine inhibits neutrophil chemotaxis beyond the chemotactic receptor-ligand interaction.
    Lohr KM; Feix JB; Kurth C
    J Infect Dis; 1984 Nov; 150(5):643-52. PubMed ID: 6092486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance of 4,5-dihydroxy-2-hexanone in the excretion kinetics of n-hexane metabolites in rat and man.
    Fedtke N; Bolt HM
    Arch Toxicol; 1987 Dec; 61(2):131-7. PubMed ID: 3439885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of n-hexane metabolites in urine of rats exposed to various concentrations of n-hexane and to its mixture with toluene or MEK.
    Iwata M; Takeuchi Y; Hisanaga N; Ono Y
    Int Arch Occup Environ Health; 1983; 53(1):1-8. PubMed ID: 6654498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of nifedipine on plasma membrane fluidity and oxidative burst of polymorphonuclear leucocytes.
    Grassi W; Serretti R; Core P; Muti S; Cervini C
    Rheumatol Int; 1995; 14(6):221-5. PubMed ID: 7597376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic renal failure: behaviour of the polymorphonuclear leukocyte membrane fluidity at baseline and after chemotactic activation.
    Caimi G; Canino B; Vaccaro F; Ventimiglia G; Oddo G; Montana M; Lo Presti R
    Nephrol Dial Transplant; 1999 Jan; 14(1):253-4. PubMed ID: 10052535
    [No Abstract]   [Full Text] [Related]  

  • 17. 4,5-Dihydroxy-2-hexanone: a new metabolite of N-hexane and of 2,5-hexanedione in rat urine.
    Fedtke N; Bolt HM
    Biomed Environ Mass Spectrom; 1987 Oct; 14(10):563-72. PubMed ID: 2962657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of 2,5-hexanedione on the induction of ornithine decarboxylase in the dorsal root ganglion of the rat.
    Myall OT; Allen SL; McLean WG
    Neurosci Lett; 1990 Jul; 114(3):305-8. PubMed ID: 2402339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of 2-hexanone and 2-hexanone metabolites on pupillomotor activity and growth.
    Abdel-Rahman MS; Saladin JJ; Bohman CE; Couri D
    Am Ind Hyg Assoc J; 1978 Feb; 39(2):94-9. PubMed ID: 637027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An increase in polymorphonuclear leucocyte chemotaxis accompanied by a change in the membrane fluidity with age during childhood.
    Yasui K; Masuda M; Tsuno T; Matsuoka T; Komiyama A; Akabane T; Murata K
    Clin Exp Immunol; 1990 Jul; 81(1):156-9. PubMed ID: 2379318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.